Interleukin-8 Messenger Ribonucleic Acid Expression Correlates with Tumor Progression, Tumor Angiogenesis, Patient Survival, and Timing of Relapse in Non–Small-Cell Lung Cancer

Ang Yuan(Hospital Kuala Lumpur), Kwen‐Tay Luh(Institute of Biomedical Sciences, Academia Sinica), Chong‐Jen Yu(National Taiwan University Hospital), Wen‐Jone Chen(Min Sheng General Hospital), Pan‐Chyr Yang(Institute of Biomedical Sciences, Academia Sinica), Fang‐Yue Lin(National Taiwan University Hospital), Sow-Hsong Kuo(Institute of Biomedical Sciences, Academia Sinica)
American Journal of Respiratory and Critical Care Medicine
November 1, 2000
10.1164/ajrccm.162.5.2002108
Cited by 172

Related Papers

International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma
|Journal of Thoracic Oncology|2011|4.8k
Osimertinib in Resected <i>EGFR</i> -Mutated Non–Small-Cell Lung Cancer
|New England Journal of Medicine|2020|1.7k
Cardiopulmonary resuscitation with assisted extracorporeal life-support versus conventional cardiopulmonary resuscitation in adults with in-hospital cardiac arrest: an observational study and propensity analysis
|The Lancet|2008|1.1k
Clinical activity of afatinib in patients with advanced non-small-cell lung cancer harbouring uncommon EGFR mutations: a combined post-hoc analysis of LUX-Lung 2, LUX-Lung 3, and LUX-Lung 6
|The Lancet Oncology|2015|980
Detection and Dynamic Changes of <i>EGFR</i> Mutations from Circulating Tumor DNA as a Predictor of Survival Outcomes in NSCLC Patients Treated with First-line Intercalated Erlotinib and Chemotherapy
|Clinical Cancer Research|2015|469